Cystadrops 3,8 mg/ml kapljice za oko, raztopina סלובניה - סלובנית - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

cystadrops 3,8 mg/ml kapljice za oko, raztopina

orphan europe s.a.r.l. - merkaptamin - kapljice za oko, raztopina - merkaptamin 3,8 mg / 1 ml - merkaptamin

Doptelet האיחוד האירופי - סלובנית - EMA (European Medicines Agency)

doptelet

swedish orphan biovitrum ab (publ) - avatrombopag maleate - trombocitopenija - antihemoragije - doptelet je primerna za zdravljenje hude trombocitopenije pri odraslih bolnikih s kronično bolezen jeter, ki so načrtovani, da opravijo invaziven postopek. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. kortikosteroidi, imunoglobulini).

Sugammadex Amomed האיחוד האירופי - סלובנית - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - zavrnitev nevromuskularne blokade, ki jo inducira rocuronium ali vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Filsuvez האיחוד האירופי - סלובנית - EMA (European Medicines Agency)

filsuvez

amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - priprave za zdravljenje ran in razjed - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.

Heplisav B האיחוד האירופי - סלובנית - EMA (European Medicines Agency)

heplisav b

dynavax gmbh - površinski antigen hepatitisa b - hepatitis b - cepiva - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

ELOCTA 1500 i.e. prašek in vehikel za raztopino za injiciranje סלובניה - סלובנית - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

elocta 1500 i.e. prašek in vehikel za raztopino za injiciranje

swedish orphan biovitrum ab (publ) - efmoroktokog alfa - prašek in vehikel za raztopino za injiciranje - efmoroktokog alfa 1500 i.e. / 1 viala - koagulacijski faktor viii

ELOCTA 250 i.e. prašek in vehikel za raztopino za injiciranje סלובניה - סלובנית - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

elocta 250 i.e. prašek in vehikel za raztopino za injiciranje

swedish orphan biovitrum ab (publ) - efmoroktokog alfa - prašek in vehikel za raztopino za injiciranje - efmoroktokog alfa 250 i.e. / 1 viala - koagulacijski faktor viii

ELOCTA 500 i.e. prašek in vehikel za raztopino za injiciranje סלובניה - סלובנית - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

elocta 500 i.e. prašek in vehikel za raztopino za injiciranje

swedish orphan biovitrum ab (publ) - efmoroktokog alfa - prašek in vehikel za raztopino za injiciranje - efmoroktokog alfa 500 i.e. / 1 viala - koagulacijski faktor viii